Research Map
The live state of the reviewed evidence — 1,762 published studies (471 human), 44 cancer pages, and 0 evidence verdicts. Educational only; not medical advice.
Most-studied medicines & supplements
By the number of distinct studies citing each across every cancer page.
- chemotherapy · 115 studies
- platinum-based chemotherapy · 105 studies
- Carboplatin · 90 studies
- Paclitaxel · 53 studies
- radiotherapy · 48 studies
- surgery · 46 studies
- Bevacizumab · 34 studies
- Cisplatin · 25 studies
Most-tracked cancers
By the number of studies in each cancer’s cited corpus.
Lung Adenocarcinoma · 4306 studiesBreast Invasive Ductal Carcinoma · 4177 studiesUterine Leiomyosarcoma · 2760 studiesProstate Cancer · 2544 studiesRhabdomyosarcoma · 2534 studiesColon Cancer · 2345 studiesNeuroblastoma · 2321 studiesMelanoma · 2315 studiesOvarian Cancer · 2133 studiesGlioblastoma · 1985 studies
Formulation & bioavailability
- Radiative magneto-thermal modeling of tri hybrid nanofluid in blood: A Biomedical intelligent framework for hyperthermia cancer therapy · Journal of thermal biology · 2026
- Hypoxia-augmented chemotherapy potentiates imaging-guided combinatorial radionuclide-sonodynamic therapy for pancreatic cancer · Journal of nanobiotechnology · 2025
- Nanomedicine in Immunotherapy for Non-Small Cell Lung Cancer: Applications and Perspectives · Small methods · 2025
- Promising biomedical applications using superparamagnetic nanoparticles · European journal of medical research · 2025
- Experimental analysis of metamaterial integrated applicator for hyperthermia cancer treatment · Scientific reports · 2025
- Engineering Sonosensitizer-Derived Nanotheranostics for Augmented Sonodynamic Therapy · Small (Weinheim an der Bergstrasse, Germany) · 2024
Clinical-trial reports
- Comparative effectiveness of immune checkpoint inhibitors in squamous vs. non-squamous cervical carcinoma: a systematic review and meta-analysis of randomized controlled trials · Translational cancer research · 2026
- KRAS G12C inhibitors versus chemotherapy in second line and beyond in adults with advanced or metastatic non-small cell lung cancer (NSCLC) harbouring the KRAS G12C mutation · The Cochrane database of systematic reviews · 2026
- Tumor Treating Fields Therapy After Stereotactic Radiosurgery for Brain Metastases From Non-Small Cell Lung Cancer: Final Results of the Phase 3 METIS Study · International journal of radiation oncology, biology, physics · 2026
- Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology Group · Neuro-oncology · 2025
- Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 study · Med (New York, N.Y.) · 2025
- Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
Recently discovered from the literature
IrinotecanDocetaxelCostunolideMethotrexateMemantineRucaparibDacarbazineEtoposideCrizotinibTrastuzumab-Deruxtecan (T-Dxd)AnastrozoleLenvatinibIntracranial SarcomaPeritoneal SarcomaOvarian SarcomaProstate AdenocarcinomaMesonephric AdenocarcinomaEndometrioid CarcinomaPulmonary Large Cell Neuroendocrine Carcinoma (Lcnec)Pancreatic CancerLarge-Cell Neuroendocrine CarcinomaRenal SarcomaLeiomyosarcomaUterine Serous Carcinoma
What changed recently
- New compound addedIrinotecan
- New compound addedDocetaxel
- Cancer page updatedProstate adenocarcinoma
- Cancer page updatedOvarian sarcoma
- Cancer page updatedPeritoneal sarcoma
- Cancer page updatedBreast invasive ductal carcinoma
- Cancer page updatedOvarian carcinosarcoma
How this is built
Every number and link here is drawn from human-approved, published content — nothing is estimated. Read how we review, or jump into the study feed.